Thu, Mar 5, 2015, 7:29 PM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Boston Scientific Corporation Message Board

  • SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Sounds like quality is now in question for NIR
      ?
      Maybe the high level executives will be arrested after
      (as happened at C.R. Bard in 1992)
      someone is
      killed from the NIR product that is not to be
      re-called
      per Larry Best press release ?? Corporation now
      laxing quality
      to make garbage ?
      How low will
      stock go ? and how quick ?
      Just questions ? Does
      anyone have answers ?

      • 2 Replies to sapworker
      • Saw two NIR on Socs placed today in difficult
        anatomy. The stents both worked very well. There is no way
        BSC would leave any product on the market that would
        risk patients. I think the market showed today that
        these are unfounded rumors. BSC is a strong company
        that is number one in virtually every division they
        compete in. With the purchase of Schnieder, their
        marketshare will only increaser plus add to the pipeline for
        future devices.

      • NIR has been blessed by every doc at every
        conference I've been to or heard about.

        PaineWebber's
        research paper dated 7/15/98 lowered BSX's eps yet they
        even stated their target price for BSX to be $100 by
        mid 1999 (not taking into account the
        split).

        The same NIR that is selling in US has been selling
        in Euorpe for along time. It is the best selling
        stent there and will be in the US soon, especailly at
        the rate they are flying out the door. Manufacturing
        can't keep up with the demand. In fact BSX has limited
        the number of hospitals that can order because of the
        demand.

        Bet: BSX will go up more than it goes down for the
        next month. I expect it to be around 80 at spilt and
        then ever upward.

        Looking at today's price I
        would say the stock has rebounded from the rumor and
        therefore most of the rumor has been taken into account as
        just competitive scare tactics.

        If you don't
        think the other stent mfgrs aren't shaking in their
        boots with the NIR now out you are sorely mistaken.

 
BSX
16.97+0.18(+1.07%)Mar 5 4:06 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Geron Corporation
NASDAQThu, Mar 5, 2015 4:00 PM EST
Orexigen Therapeutics, Inc.
NASDAQThu, Mar 5, 2015 4:00 PM EST
Orbital ATK, Inc.
NYSEThu, Mar 5, 2015 4:02 PM EST